{"id":"https://openalex.org/W4414769486","doi":"https://doi.org/10.7759/cureus.93737","title":"Monocyte to High-Density Lipoprotein Ratio (MHR) and Monocyte to Lymphocyte Ratio (MLR) in Vitiligo: A Case-Control Study","display_name":"Monocyte to High-Density Lipoprotein Ratio (MHR) and Monocyte to Lymphocyte Ratio (MLR) in Vitiligo: A Case-Control Study","publication_year":2025,"publication_date":"2025-10-02","ids":{"openalex":"https://openalex.org/W4414769486","doi":"https://doi.org/10.7759/cureus.93737","pmid":"https://pubmed.ncbi.nlm.nih.gov/41185791"},"language":"en","primary_location":{"id":"doi:10.7759/cureus.93737","doi":"https://doi.org/10.7759/cureus.93737","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.93737","pdf_url":"https://www.cureus.com/articles/407128-monocyte-to-high-density-lipoprotein-ratio-mhr-and-monocyte-to-lymphocyte-ratio-mlr-in-vitiligo-a-case-control-study.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.cureus.com/articles/407128-monocyte-to-high-density-lipoprotein-ratio-mhr-and-monocyte-to-lymphocyte-ratio-mlr-in-vitiligo-a-case-control-study.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5119823682","display_name":"Vaniyapilly S Aathira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129734738","display_name":"All India Institute of Medical Sciences Raipur","ror":"https://ror.org/02ys8pq62","country_code":"IN","type":"education","lineage":["https://openalex.org/I129734738"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Vaniyapilly  S Aathira","raw_affiliation_strings":["Dermatology, All India Institute of Medical Sciences, Raipur, Raipur, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology, All India Institute of Medical Sciences, Raipur, Raipur, IND","institution_ids":["https://openalex.org/I129734738"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009528353","display_name":"Satyaki Ganguly","orcid":"https://orcid.org/0000-0002-8771-6858","observed_orcids":["https://orcid.org/0000-0002-8771-6858"]},"institutions":[{"id":"https://openalex.org/I129734738","display_name":"All India Institute of Medical Sciences Raipur","ror":"https://ror.org/02ys8pq62","country_code":"IN","type":"education","lineage":["https://openalex.org/I129734738"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Satyaki Ganguly","raw_affiliation_strings":["Dermatology, All India Institute of Medical Sciences, Raipur, Raipur, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology, All India Institute of Medical Sciences, Raipur, Raipur, IND","institution_ids":["https://openalex.org/I129734738"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I129734738"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.22445877,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":"10","first_page":"e93737","last_page":"e93737"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.8618000149726868,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.8618000149726868,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.10679999738931656,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vitiligo","display_name":"vitiligo","score":1.0},{"id":"https://openalex.org/keywords/monocyte-to-high-density-lipoprotein-ratio","display_name":"monocyte to high-density lipoprotein ratio","score":0.9860000014305115},{"id":"https://openalex.org/keywords/monocyte-to-lymphocyte-ratio","display_name":"monocyte-to-lymphocyte ratio","score":1.0},{"id":"https://openalex.org/keywords/platelet-to-lymphocyte-ratio","display_name":"platelet-to-lymphocyte ratio","score":0.9279999732971191},{"id":"https://openalex.org/keywords/neutrophil-to-lymphocyte-ratio","display_name":"neutrophil-to-lymphocyte ratio","score":1.0},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.6259999871253967},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.9660000205039978},{"id":"https://openalex.org/keywords/stable-vitiligo","display_name":"stable vitiligo","score":0.9850000143051147},{"id":"https://openalex.org/keywords/systemic-therapy-response","display_name":"systemic therapy response","score":0.781000018119812},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.8519999980926514}],"concepts":[{"id":"https://openalex.org/C2779980618","wikidata":"https://www.wikidata.org/wiki/Q180152","display_name":"Vitiligo","level":2,"score":0.9624999761581421},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9165999889373779},{"id":"https://openalex.org/C2781184567","wikidata":"https://www.wikidata.org/wiki/Q107244","display_name":"Monocyte","level":2,"score":0.7540000081062317},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.6699000000953674},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.5835000276565552},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5062000155448914},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46880000829696655},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.43470001220703125},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.3736000061035156},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.36250001192092896},{"id":"https://openalex.org/C2778963024","wikidata":"https://www.wikidata.org/wiki/Q17132454","display_name":"Neutrophil to lymphocyte ratio","level":3,"score":0.3084999918937683},{"id":"https://openalex.org/C2778740727","wikidata":"https://www.wikidata.org/wiki/Q12055129","display_name":"Mixed lymphocyte reaction","level":4,"score":0.303600013256073},{"id":"https://openalex.org/C2778270857","wikidata":"https://www.wikidata.org/wiki/Q2723972","display_name":"Lipid profile","level":3,"score":0.30250000953674316},{"id":"https://openalex.org/C2994423189","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Total cholesterol","level":3,"score":0.27950000762939453},{"id":"https://openalex.org/C146304588","wikidata":"https://www.wikidata.org/wiki/Q961652","display_name":"Case-control study","level":2,"score":0.2662000060081482},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.26179999113082886},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.2547000050544739}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.7759/cureus.93737","doi":"https://doi.org/10.7759/cureus.93737","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.93737","pdf_url":"https://www.cureus.com/articles/407128-monocyte-to-high-density-lipoprotein-ratio-mhr-and-monocyte-to-lymphocyte-ratio-mlr-in-vitiligo-a-case-control-study.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},{"id":"pmid:41185791","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41185791","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:11388839","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12579584","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.7759/cureus.93737","doi":"https://doi.org/10.7759/cureus.93737","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.93737","pdf_url":"https://www.cureus.com/articles/407128-monocyte-to-high-density-lipoprotein-ratio-mhr-and-monocyte-to-lymphocyte-ratio-mlr-in-vitiligo-a-case-control-study.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320324337","display_name":"All-India Institute of Medical Sciences","ror":"https://ror.org/02dwcqs71"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4414769486.pdf","grobid_xml":"https://content.openalex.org/works/W4414769486.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1506943947","https://openalex.org/W1972518074","https://openalex.org/W2006016016","https://openalex.org/W2035731392","https://openalex.org/W2095688886","https://openalex.org/W2163453199","https://openalex.org/W2342442753","https://openalex.org/W2606342314","https://openalex.org/W2767540638","https://openalex.org/W2921177837","https://openalex.org/W2971236891","https://openalex.org/W3041609997","https://openalex.org/W3046366318","https://openalex.org/W3080873582","https://openalex.org/W3093660446","https://openalex.org/W4200255435","https://openalex.org/W4387995903","https://openalex.org/W4392700514","https://openalex.org/W4393228381","https://openalex.org/W4399197194"],"related_works":[],"abstract_inverted_index":{"Background":[0],"Vitiligo":[1,150],"is":[2],"a":[3,64],"disorder":[4],"influenced":[5],"by":[6],"oxidative":[7,48],"stress":[8,49],"and":[9,41,54,60,70,81,87,101,111,121,128,146,158],"systemic":[10,134,203],"inflammation.":[11],"While":[12],"previous":[13],"studies":[14],"used":[15],"difficult-to-perform":[16],"markers,":[17],"research":[18],"on":[19,77,133],"readily":[20],"available":[21],"markers":[22,57,198],"like":[23],"the":[24],"monocyte":[25,31],"to":[26,32,37,43,123,162,166,186],"high-density":[27],"lipoprotein":[28],"ratio":[29,34,39,45],"(MHR),":[30],"lymphocyte":[33,38,44],"(MLR),":[35],"platelet":[36],"(PLR),":[40],"neutrophil":[42],"(NLR)":[46],"for":[47,118],"in":[50,58,175,183,196,205],"vitiligo":[51,62,79,94,100,169,188],"remains":[52],"limited,":[53],"assessing":[55],"these":[56,176,197],"stable":[59,105,168,187],"unstable":[61,99,184],"represents":[63],"novel":[65],"area":[66],"of":[67,85,92,202],"research.":[68],"Materials":[69],"methods":[71],"This":[72],"case-control":[73],"study":[74],"was":[75,180,191],"conducted":[76],"72":[78,93],"patients":[80,97,103,132,151,170],"an":[82],"equal":[83],"number":[84],"age":[86],"gender-matched":[88],"healthy":[89,163],"controls.":[90,164],"Out":[91],"patients,":[95],"57":[96],"had":[98,104,152,171],"15":[102],"vitiligo.":[106],"Complete":[107],"blood":[108],"count":[109],"(CBC)":[110],"fasting":[112],"lipid":[113],"profile":[114],"(FLP)":[115],"were":[116,136,143],"performed":[117],"both":[119],"cases":[120],"controls":[122],"assess":[124],"MHR,":[125,155],"MLR,":[126,156],"NLR,":[127,157],"PLR.":[129],"Further,":[130],"19":[131,206],"therapy":[135],"reassessed":[137],"after":[138,147,199],"one":[139,200],"month.":[140],"Their":[141],"ratios":[142],"compared":[144,161,185],"before":[145],"treatment.":[148],"Results":[149],"significantly":[153,181],"higher":[154,182],"PLR":[159,179],"as":[160],"Compared":[165],"controls,":[167],"no":[172,192],"significant":[173,194],"difference":[174],"markers.":[177],"Only":[178],"patients.":[189,207],"There":[190],"statistically":[193],"reduction":[195],"month":[201],"treatment":[204]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2025-10-10T00:00:00"}